GUANGZHOU SHIFANG INTERNATIONAL TRADE CO – Trademark Portfolio

Entity Type: 99

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VZOXAINS. The owner is based in GUANGZHOU.

ROOM Q1078-1002 NO. 80 YONGTAI

MODAO SOUTH STREET BAIYUN DIST,

GUANGZHOU 510442 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VZOXAINS
VZOXAINS
Registered 2022

Trademark Classifications

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does GUANGZHOU SHIFANG INTERNATIONAL TRADE CO have?

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU SHIFANG INTERNATIONAL TRADE CO file in?

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GUANGZHOU SHIFANG INTERNATIONAL TRADE CO's most well-known trademarks?

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO's registered trademark portfolio includes well-known marks such as VZOXAINS. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU SHIFANG INTERNATIONAL TRADE CO's trademark registration success rate?

GUANGZHOU SHIFANG INTERNATIONAL TRADE CO has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.